期刊文献+

从2010-2014年度国家自然科学基金资助情况分析我国肝病研究进展 被引量:1

The funded projects and related progresses in the field of liver diseases from National Natural Science Foundation of China during 2010 to 2014
原文传递
导出
摘要 目的 通过对2010-2014年度肝病领域国家自然科学基金资助情况的分析,反映该领域的研究现状,并对发展趋势提出思考.方法 统计2010--2014年5年来国家自然科学基金在肝病领域资助的具体情况,分析项目的领域分布、申请人及依托单位情况、资助金额等.结果 (1)肝病领域年均获资助624.4项,年均资助金额32 183.92万元;(2)大项目比例偏低;(3)近半数研究项目集中在肝癌领域;(4)80%的资助项目集中在19.03%的依托单位.结论 在国家自然科学基金资助下,肝病领域基础研究有了长足进展,虽然存在着整体水平偏低,高层次研究项目少,研究方向与临床需求不完全一致等问题,但是在肝病免疫学方面取得了一系列重要的发现和相关应用成果. Objective To analyze the projects funded by National Natural Science Foundation of China(NSFC) in the field of liver diseases during 2010 to 2014.Methods The projects in the field of liver disease were statistically analyzed regarding the subordinate branches and distribution of the applicants and registered institutions.Results 1.There were 624.4 projects and 321,839,200 yuans annual funded in the field of liver diseases; 2.The percentage of the key/major projects was lower than the average level; 3.Nearly half of the projects funded focus on the liver cancer; 4.19.03% of registered institution got 80% of funded projects.Conclusions With the continuous funding aid from NSFC,the fundamental research in this field has progressed significantly,especially in immunology.However,the overall research capacity still need to be further improved and the research direction need to be connected more closely to the clinical requirement to meet the translational medicine demand.
出处 《中华医学科研管理杂志》 2015年第3期235-238,共4页 Chinese Journal of Medical Science Research Management
基金 国家自然科学基金面上项目“酒精性肝硬化的临床流行病学和NK细胞免疫学特征研究”(81172779)
关键词 国家自然科学基金 肝病 发展现状与趋势 National Natural Science Foundation of China Liver diseases Development status and trends
  • 相关文献

参考文献3

二级参考文献18

  • 1Qiujin Shen*, Jia Fan*, Xin-Rong Yang*, Yexiong Tan*, Weifeng Zhao*,Wenxin Qin.et al Serum DKK1 as a protein biomarker for the diagnosis ofhepatocellular carcinoma: a large-scale, multicentre study. www.thelancet.com/oncology Published online June 26, 2012 http://dx.doi.org/10.1016/S 1470-2045 ( 12)70233 -4.
  • 2Phillips S,Chokshi S,Riva A. CD8(+) T cell control of hepatitis B virus replication:direct comparison between cytolytic and noncytolytic functions[J].{H}Journal of Immunology,2010.287-295.
  • 3Morón G,Dadaglio G,Leclerc C. New tools for antigen delivery to the MHC class Ⅰ pathway[J].{H}Trends in Immunology,2004.92-97.
  • 4Chen X,Lai J,Pan Q. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice[J].{H}VACCINE,2010.3913-3919.
  • 5Chen W,Shi M,Shi F. HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes[J].{H}Hepatology Research,2009.355-365.
  • 6Hulpke S,BaldaufC,Tampé R. Molecular architecture of the MHC Ⅰ peptide-loading complex:one tapasin molecule is essential and sufficient for antigen processing[J].{H}FASEB JOURNAL,2012.5071-5080.
  • 7Halenius A,Hauka S,D51ken L. Human cytomegalovirus disrupts the major histocompatibility complex class Ⅰ peptide-loading complex and inhibits tapasin gene transcription[J].{H}Journal of Virology,2011.3473-3485.
  • 8Williams R. Global challenges in liver disease[J].{H}HEPATOLOGY,2006.521-526.
  • 9Kim D,Jeon C,Kim JH. Cytoplasmic transduction peptide (CTP):new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo[J].{H}Experimental Cell Research,2006.1277-1288.
  • 10Halenius A,Hauka S,D(o)1ken L. Human cytomegalovirus disrupts the major histocompatibility complex class Ⅰ peptide-loading complex and inhibits tapasin gene transcription[J].{H}Journal of Virology,2011.3473-3485.

共引文献758

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部